Hackman Jeffrey S. (CIK 1926254) reported 9 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-01). Recent activity: Buy FENC (1,159 shares), Buy FENC (1,159 shares), Buy FENC (1,159 shares), Buy FENC (16,695 shares), Buy FENC (1,159 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-01 | FENNEC PHARMACEUTICALS INC. (FENC) | Chief Executive Officer | Buy | 1,159 | $0 |
| 2026-06-01 | FENNEC PHARMACEUTICALS INC. (FENC) | Chief Executive Officer | Buy | 1,159 | $0 |
| 2026-05-01 | FENNEC PHARMACEUTICALS INC. (FENC) | Chief Executive Officer | Buy | 1,159 | $0 |
| 2026-04-02 | FENNEC PHARMACEUTICALS INC. (FENC) | Chief Executive Officer | Buy | 16,695 | $0 |
| 2026-04-02 | FENNEC PHARMACEUTICALS INC. (FENC) | Chief Executive Officer | Buy | 1,159 | $0 |
| 2026-04-02 | FENNEC PHARMACEUTICALS INC. (FENC) | Chief Executive Officer | Buy | 13,943 | $0 |
| 2026-02-19 | FENNEC PHARMACEUTICALS INC. (FENC) | Chief Executive Officer | Buy | 13,710 | $0 |
| 2025-05-19 | FENNEC PHARMACEUTICALS INC. (FENC) | Chief Executive Officer | Buy | 1,035 | $6,986 |
| 2025-05-19 | FENNEC PHARMACEUTICALS INC. (FENC) | Chief Executive Officer | Buy | 13,965 | $97,615 |
Source: SEC Form 4 filings · as of 2026-07-01